Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States (updated 12/17/2021)

Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States - recent changes (last updated December 17, 2021):
Updated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine.